Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Breast Neoplasms 2Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Heart Failure 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Cardiovascular Diseases 1Cardiotoxicity 1Atherosclerosis 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT03219372 2021-01-22

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Cedars-Sinai Medical Center

Phase 2 Terminated
1 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT03490461 2018-04-06

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Yonsei University

Completed
350 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02819869 2017-04-19

The Combination Effect of Statin Plus Metformin on Relapse-free

Taipei Medical University WanFang Hospital

Phase 2 Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡